557 related articles for article (PubMed ID: 7697216)
1. Immunohistochemical detection of p53 in cervical epithelial lesions with or without infection of human papillomavirus types 16 and 18.
Akasofu M; Oda Y
Virchows Arch; 1995; 425(6):593-602. PubMed ID: 7697216
[TBL] [Abstract][Full Text] [Related]
2. The possible role of bcl-2 expression in the progression of tumors of the uterine cervix.
Saegusa M; Takano Y; Hashimura M; Shoji Y; Okayasu I
Cancer; 1995 Dec; 76(11):2297-303. PubMed ID: 8635035
[TBL] [Abstract][Full Text] [Related]
3. p53 immunoreactivity in cervical intraepithelial neoplasia and non-neoplastic cervical squamous epithelium.
Jeffers MD; Richmond J; Farquharson M; McNicol AM
J Clin Pathol; 1994 Dec; 47(12):1073-6. PubMed ID: 7876377
[TBL] [Abstract][Full Text] [Related]
4. p53 status and human papillomavirus infection in Thai women with cervical carcinoma.
Limpaiboon T; Pooart J; Bhattarakosol P; Niruthisard S; Chantratita W; Lulitanond V
Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):66-71. PubMed ID: 11023067
[TBL] [Abstract][Full Text] [Related]
5. Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix.
Yamashita T; Yaginuma Y; Saitoh Y; Kawai K; Kurakane T; Hayashi H; Ishikawa M
Carcinogenesis; 1999 Sep; 20(9):1733-6. PubMed ID: 10469618
[TBL] [Abstract][Full Text] [Related]
6. p53 expression and genetic evidence for viral infection in intraepithelial neoplasia of the uterine cervix.
Vecchione A; Cermele C; Giovagnoli MR; Valli C; Alimandi M; Carico E; Esposito DL; Mariani-Costantini R; French D
Gynecol Oncol; 1994 Dec; 55(3 Pt 1):343-8. PubMed ID: 7835772
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of ras oncogenes in CIN III and in stage I and II invasive squamous cell carcinoma of the uterine cervix.
O'Leary JJ; Landers RJ; Silva I; Uhlmann V; Crowley M; Healy I; Luttich K
J Clin Pathol; 1998 Aug; 51(8):576-82. PubMed ID: 9828814
[TBL] [Abstract][Full Text] [Related]
8. G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value.
Cho NH; Lim SY; Kim YT; Kim D; Kim YS; Kim JW
Gynecol Oncol; 2003 Jul; 90(1):15-22. PubMed ID: 12821336
[TBL] [Abstract][Full Text] [Related]
9. [Ha-ras and p53 gene mutations scanned by PCR-SSCP in premalignant and malignant lesions of the uterine cervix associated with human papillomavirus].
Alonio LV; Dalbert D; Picconi MA; Cervantes Vazquez G; García Carrancá A; Distefano AL; Mural J; Bartt O; Bazan G; Teyssie AR
Medicina (B Aires); 2000; 60(6):895-901. PubMed ID: 11436698
[TBL] [Abstract][Full Text] [Related]
10. Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.
Hudelist G; Manavi M; Pischinger KI; Watkins-Riedel T; Singer CF; Kubista E; Czerwenka KF
Gynecol Oncol; 2004 Mar; 92(3):873-80. PubMed ID: 14984955
[TBL] [Abstract][Full Text] [Related]
11. Correlation of apoptosis with tumour cell differentiation, progression, and HPV infection in cervical carcinoma.
Shoji Y; Saegusa M; Takano Y; Ohbu M; Okayasu I
J Clin Pathol; 1996 Feb; 49(2):134-8. PubMed ID: 8655679
[TBL] [Abstract][Full Text] [Related]
12. The presence of HPV 16, 18 and p53 immunohistochemical staining in tumor tissue of Israeli Jewish women with cervical and vulvar neoplasia.
Menczer J; Fintsi Y; Arbel-Alon S; Tell L; Friedman E; Jackman A; Sherman L
Eur J Gynaecol Oncol; 2000; 21(1):30-4. PubMed ID: 10726615
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis of human papillomavirus infection in paraffin-embedded cervical tissues by gene clip technology].
Lü YL; Zhong M; Zhao P
Zhonghua Bing Li Xue Za Zhi; 2006 Dec; 35(12):719-21. PubMed ID: 17374254
[TBL] [Abstract][Full Text] [Related]
14. Cervical squamous dysplasias and carcinomas with immunodetectable p53 frequently contain HPV.
Mittal KR; Lin O; Chan W; Goswami S; Demopoulos RI
Gynecol Oncol; 1995 Sep; 58(3):289-94. PubMed ID: 7672694
[TBL] [Abstract][Full Text] [Related]
15. HPV in situ hybridization: impact of different protocols on the detection of integrated HPV.
Hopman AH; Kamps MA; Smedts F; Speel EJ; Herrington CS; Ramaekers FC
Int J Cancer; 2005 Jun; 115(3):419-28. PubMed ID: 15688369
[TBL] [Abstract][Full Text] [Related]
16. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
[TBL] [Abstract][Full Text] [Related]
17. Signal-amplified colorimetric in situ hybridization for assessment of human papillomavirus infection in cervical lesions.
Birner P; Bachtiary B; Dreier B; Schindl M; Joura EA; Breitenecker G; Oberhuber G
Mod Pathol; 2001 Jul; 14(7):702-9. PubMed ID: 11455003
[TBL] [Abstract][Full Text] [Related]
18. Coexisting high-grade glandular and squamous cervical lesions and human papillomavirus infections.
Bekkers RL; Bulten J; Wiersma-van Tilburg A; Mravunac M; Schijf CP; Massuger LF; Quint WG; Melchers WJ
Br J Cancer; 2003 Sep; 89(5):886-90. PubMed ID: 12942122
[TBL] [Abstract][Full Text] [Related]
19. Papillomavirus, p53 alteration, and primary carcinoma of the vulva.
Pilotti S; D'Amato L; Della Torre G; Donghi R; Longoni A; Giarola M; Sampietro G; De Palo G; Pierotti MA; Rilke F
Diagn Mol Pathol; 1995 Dec; 4(4):239-48. PubMed ID: 8634779
[TBL] [Abstract][Full Text] [Related]
20. HPV 16 detection in cervical lesions, physical state of viral DNA and changes in p53 gene.
do Horto dos Santos Oliveira L; Rodrigues Ede V; de Salles Lopes AP; Fernandez Ade P; Cavalcanti SM
Sao Paulo Med J; 2003 Mar; 121(2):67-71. PubMed ID: 12870053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]